27707823|t|Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades
27707823|a|Toxoplasma gondii is an obligate intracellular protozoan infecting up to one-third of the world's population, constituting a life threat if transmitted from mother to child during pregnancy. In Portugal, there is a lack of knowledge of the current epidemiological situation, as the unique toxoplasmosis National Serological Survey was performed in 1979/1980. We studied the seroprevalence trends in the Portuguese general population over the past 3 decades, by assessing chronological spread cross-sectional studies, with special focus on women of childbearing age, by age group, region and gender. The T. gondii overall seroprevalence decreased from 47% in 1979/1980 to 22% (95% CI 20% to 24%) in 2013. Generally, we observed that the prevalence of T. gondii IgG increased significantly with age and it decreased over time, both in the general population and in the childbearing women (18% prevalence in 2013). The scenario observed for the latter indicates that more than 80% of childbearing women are susceptible to primary infection yielding a risk of congenital toxoplasmosis and respective sequelae. Since there is no vaccine to prevent human toxoplasmosis, the improvement of primary prevention constitutes a major tool to avoid infection in such susceptible groups.
27707823	0	17	Toxoplasma gondii	T204	C0040557
27707823	18	32	seroprevalence	T062	C0600367
27707823	40	61	Portuguese population	T098	C0032730
27707823	83	106	cross-sectional studies	T062	C0010362
27707823	122	129	decades	T081	C2981279
27707823	130	147	Toxoplasma gondii	T204	C0040557
27707823	163	176	intracellular	T082	C0178719
27707823	177	186	protozoan	T204	C0033739
27707823	220	238	world's population	T098	C2700280
27707823	255	266	life threat	T033	C2826244
27707823	270	281	transmitted	T070	C1521797
27707823	287	293	mother	T099	C0026591
27707823	297	302	child	T100	C0008059
27707823	310	319	pregnancy	T040	C0032961
27707823	324	332	Portugal	T083	C0032729
27707823	378	403	epidemiological situation	T169	C1516907
27707823	419	432	toxoplasmosis	T047	C0040558
27707823	433	460	National Serological Survey	T062	C0681817
27707823	504	518	seroprevalence	T062	C0600367
27707823	533	562	Portuguese general population	T098	C0032730
27707823	579	586	decades	T081	C2981279
27707823	622	645	cross-sectional studies	T062	C0010362
27707823	669	674	women	T098	C0043210
27707823	678	690	childbearing	T039	C0031845
27707823	691	694	age	T032	C0001779
27707823	699	708	age group	T100	C0027362
27707823	710	716	region	T083	C0017446
27707823	721	727	gender	T032	C0079399
27707823	733	742	T. gondii	T204	C0040557
27707823	751	765	seroprevalence	T062	C0600367
27707823	866	876	prevalence	T081	C0033105
27707823	880	889	T. gondii	T204	C0040557
27707823	890	893	IgG	T116,T121,T129	C0020852
27707823	923	926	age	T032	C0001779
27707823	949	953	time	T079	C0040223
27707823	975	985	population	T081	C0032659
27707823	997	1009	childbearing	T039	C0031845
27707823	1010	1015	women	T098	C0043210
27707823	1021	1031	prevalence	T081	C0033105
27707823	1111	1123	childbearing	T039	C0031845
27707823	1124	1129	women	T098	C0043210
27707823	1134	1145	susceptible	T169	C0231204
27707823	1157	1166	infection	T046	C3714514
27707823	1178	1182	risk	T078	C0035647
27707823	1186	1210	congenital toxoplasmosis	T047	C0040560
27707823	1226	1234	sequelae	T046	C0243088
27707823	1251	1253	no	T033	C1513916
27707823	1254	1261	vaccine	T121,T129	C0042210
27707823	1273	1278	human	T016	C0086418
27707823	1279	1292	toxoplasmosis	T047	C0040558
27707823	1313	1331	primary prevention	T061	C0033144
27707823	1366	1375	infection	T046	C3714514
27707823	1384	1395	susceptible	T169	C0231204
27707823	1396	1402	groups	T098	C1257890